DuPont Receives 'Moderate Buy' Rating from Analysts

Seventeen analysts cover the specialty materials company, with most recommending investors buy the stock.

Apr. 4, 2026 at 8:40am

An extreme close-up of the gears, pipes, and heavy metal components that make up the industrial machinery and equipment of a large manufacturing facility, conveying a sense of the tangible, physical power and security of a major specialty materials company.The intricate machinery and infrastructure that powers a major specialty materials company like DuPont reflects the institutional strength and financial security behind the brand.Wilmington Today

Shares of DuPont de Nemours, Inc. (NYSE:DD) have received an average 'Moderate Buy' rating from the 17 analysts currently covering the company, according to a MarketBeat report. One analyst has a 'Sell' rating, three have a 'Hold' rating, 12 have a 'Buy' rating, and one has a 'Strong Buy' rating on the stock. The average 12-month price target among the analysts is $51.86.

Why it matters

DuPont is a major specialty materials and chemicals company that has undergone significant restructuring in recent years. The 'Moderate Buy' rating from analysts suggests they see potential upside in the stock, despite some lingering concerns.

The details

Several analysts have recently weighed in on DuPont's stock. Zacks Research upgraded the shares from 'Hold' to 'Strong Buy' in February. Wolfe Research raised its price target from $49 to $54 and maintained an 'Outperform' rating. UBS Group lifted its price objective from $49 to $56 and kept a 'Buy' rating. BMO Capital Markets increased its target price from $50 to $60 and reiterated an 'Outperform' rating.

  • The analysts' average 12-month price target was reported on April 4, 2026.
  • Zacks Research upgraded DuPont to 'Strong Buy' on February 12, 2026.
  • Wolfe Research raised its price target on February 11, 2026.
  • UBS Group lifted its price objective on February 11, 2026.
  • BMO Capital Markets increased its target price on February 12, 2026.

The players

DuPont de Nemours, Inc.

A global science and engineering company that develops and supplies specialty materials, chemicals, and industrial biosciences for a wide range of markets.

Zacks Research

An investment research firm that provides stock analysis and ratings.

Wolfe Research

An independent equity research firm.

UBS Group

A global financial services firm.

BMO Capital Markets

The investment banking arm of Bank of Montreal.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee

The takeaway

The 'Moderate Buy' rating from analysts suggests DuPont's restructuring efforts and focus on specialty materials are starting to pay off, though the company still faces some lingering challenges.